699 related articles for article (PubMed ID: 24555745)
21. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
Tirosh A; El Lakis M; Green P; Nockel P; Patel D; Nilubol N; Gara SK; Keutgen XM; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2018 Apr; 103(4):1631-1638. PubMed ID: 29294023
[TBL] [Abstract][Full Text] [Related]
22. Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.
Kang HC; Kim IJ; Park JH; Shin Y; Jang SG; Ahn SA; Park HW; Lim SK; Oh SK; Kim DJ; Lee KW; Choi YS; Park YJ; Lee MR; Kim DW; Park JG
Oncol Rep; 2005 Oct; 14(4):879-83. PubMed ID: 16142346
[TBL] [Abstract][Full Text] [Related]
23. The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.
Kaelin WG
Cold Spring Harb Symp Quant Biol; 2005; 70():159-66. PubMed ID: 16869749
[TBL] [Abstract][Full Text] [Related]
24. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
25. Two pediatric patients with Von Hippel-Lindau disease type 2b: from patient to screening, from screening to patient.
Gonc N; Engiz O; Neumann HP; Demirbilek H; Ozon A; Alikasifoglu A; Kandemir N
J Pediatr Endocrinol Metab; 2011; 24(1-2):109-12. PubMed ID: 21528828
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
[TBL] [Abstract][Full Text] [Related]
27. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531
[TBL] [Abstract][Full Text] [Related]
28. von Hippel-Lindau disease.
Couch V; Lindor NM; Karnes PS; Michels VV
Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
[TBL] [Abstract][Full Text] [Related]
29. [Von Hippel-Lindau disease: family study].
González Escobar AB; Morillo Sánchez MJ; García-Campos JM
Arch Soc Esp Oftalmol; 2012 Nov; 87(11):368-72. PubMed ID: 23058196
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease.
Wu X; Chen L; Zhang Y; Xie H; Xue M; Wang Y; Huang H
BMC Med Genet; 2018 Nov; 19(1):204. PubMed ID: 30477447
[TBL] [Abstract][Full Text] [Related]
31. [Mitral regurgitation of unknown etiology in a 20-year-old patient].
Caro J; Inmaculada Navarro-Hidalgo M; Bonanad C; Real JT; Ascaso JF
Endocrinol Nutr; 2012 May; 59(5):333-5. PubMed ID: 22244657
[No Abstract] [Full Text] [Related]
32. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlations in von Hippel-Lindau disease.
Ong KR; Woodward ER; Killick P; Lim C; Macdonald F; Maher ER
Hum Mutat; 2007 Feb; 28(2):143-9. PubMed ID: 17024664
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.
Toy BC; Agrón E; Nigam D; Chew EY; Wong WT
Ophthalmology; 2012 Dec; 119(12):2622-30. PubMed ID: 22906772
[TBL] [Abstract][Full Text] [Related]
35. Genotype-phenotype correlation in von Hippel-Lindau syndrome.
Friedrich CA
Hum Mol Genet; 2001 Apr; 10(7):763-7. PubMed ID: 11257110
[TBL] [Abstract][Full Text] [Related]
36. Genotype-phenotype correlation in ocular von Hippel-Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype.
Mettu P; Agrón E; Samtani S; Chew EY; Wong WT
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4464-70. PubMed ID: 20375333
[TBL] [Abstract][Full Text] [Related]
37. Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.
Gergics P; Patocs A; Toth M; Igaz P; Szucs N; Liko I; Fazakas F; Szabo I; Kovacs B; Glaz E; Racz K
Eur J Endocrinol; 2009 Sep; 161(3):495-502. PubMed ID: 19574279
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.
Vikkath N; Valiyaveedan S; Nampoothiri S; Radhakrishnan N; Pillai GS; Nair V; Pooleri GK; Mathew G; Menon KN; Ariyannur PS; Pillai AB
Fam Cancer; 2015 Dec; 14(4):585-94. PubMed ID: 25952756
[TBL] [Abstract][Full Text] [Related]
39. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
40. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
Opocher G; Conton P; Schiavi F; Macino B; Mantero F
Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]